Optimizing Varicella Vaccination Strategy: A Study on Age and Dose Impacts on Antibody Levels

Optimizing Varicella Vaccination Strategy: A Study on Age and Dose Impacts on Antibody Levels

Seropositivity study of Varicella in Healthy Populations in Guangzhou, China. Infection with varicella-zoster virus (VZV) leads to skin and mucous membranes blisters and the complications can be life threatening. A seroepidemiological study conducted from 2020 to 2022 in Guangzhou, China, aimed to e...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qing He, Yang Xu, Yilan Li, Pinting Zhu, Lei Luo
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Vaccines
Subjects:	varicella seroepidemiology vaccination
Online Access:	https://www.mdpi.com/2076-393X/13/1/23
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The impact of the implementation of the two-dose varicella vaccine immunization strategy in Quzhou: A retrospective birth cohort study
by: Tingcui Wen, et al.
Published: (2024-12-01)

Seroepidemiological survey of the population 10 years after the implementation of the varicella vaccine 2-dose immunization strategy
by: Quanjun Fang, et al.
Published: (2025-12-01)

SUBSTANTIATION AND EXPERIENCE OF THE VARICELLA VACCINE USAGE IN VOLGOGRAD
by: L. V. Kramar’, et al.
Published: (2012-05-01)

Varicella-zoster virus seroprevalence among reproductive-age women in Iran: a meta-analysis and implications for targeted immunization
by: Morteza Pourahmad, et al.
Published: (2025-08-01)

The protective effects of two varicella vaccination strategies: A Bayesian modeling study in two megacities in South China
by: Xing Huang, et al.
Published: (2025-12-01)

Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus
by: Giacomo Casabona, et al.
Published: (2025-12-01)

Impact of vaccination strategy adjustments on antibody levels against measles, rubella, mumps, and varicella in China: a single-center serological survey
by: Zhixin Geng, et al.
Published: (2025-08-01)

Research Progress on Varicella-Zoster Virus Vaccines
by: Hongjing Liu, et al.
Published: (2025-07-01)

Analysis of antibody dynamics in Chinese children aged 1-3 years after single-dose varicella vaccination: A 42 months prospective study
by: Xiang Sun, et al.
Published: (2024-12-01)

Hospital-based seroepidemiological analysis of varicella antibodies in children without history of varicella disease
by: Zhongyang Zhang, et al.
Published: (2025-03-01)

Cost effectiveness analysis of universal varicella vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-10-01)

Expanded spectrum of varicella disease and the need for vaccination in India
by: Padma Srikanth, et al.
Published: (2024-12-01)

Analysis of sero-epidemiological characteristics of varicella in healthy children in Wuxi, China
by: Lingling Wang, et al.
Published: (2024-12-01)

Paediatric varicella epidemiology in urban Beijing, China, 2014–2023
by: Dan Yu, et al.
Published: (2025-12-01)

Modeling the effects of improving varicella vaccination coverage on clinical and economic outcomes in Peru
by: John C. Lang, et al.
Published: (2025-12-01)

Antibody Titer Against Varicella Zoster Virus and Recombinant Varicella Zoster Vaccine in Hemodialysis Patients: What We Know, What We Should Know
by: Francesca K. Martino, et al.
Published: (2025-04-01)

Varicella and Zoster Vaccination Strategies in Immunosuppressed Pediatric Transplant Recipients
by: Christopher Hartley, et al.
Published: (2025-05-01)

POST-EXPOSURE PROPHYLAXIS OF VARICELLA IN ORDER TO STOP INFECTION OUTBREAKS IN KRASNOYARSK CHILDREN ORGANIZED GROUPS
by: N. V. Bakhareva, et al.
Published: (2012-03-01)

Immunogenicity and safety of the domestic and imported live-attenuated varicella vaccine in healthy Chinese populations: a systematic review and meta-analysis
by: Yemin Yuan, et al.
Published: (2025-07-01)

Epidemiological characteristics of breakthrough varicella cases among students in Jiulongpo District, Chongqing: implications for vaccination strategies
by: Huixian Zhou, et al.
Published: (2025-06-01)

Varicella Zoster vaccination in hemodialysis patients: The state of the art
by: Laura Gobbi, et al.
Published: (2023-12-01)

Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
by: Valentina Carta, et al.
Published: (2024-12-01)

The impact of varicella vaccination: A 2005–2019 interrupted time series analysis
by: Katherina U. Miranda, et al.
Published: (2023-12-01)

Experience of the Varicella Vaccine Introduction into Regional Vaccination Shedule of the Russian Federation
by: M. A. Baryshev, et al.
Published: (2020-01-01)

Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of Shenzhen,China
by: Ziqi Wang, et al.
Published: (2024-12-01)

Surveillance of Adverse Events Following Varicella Vaccine Immunization in Zhejiang Province, China, from 2020 to 2022
by: Hui Liang, et al.
Published: (2025-01-01)

Post-varicella vaccination uveitis in a child with nephrotic syndrome receiving immunosuppressive treatment: a case report
by: Catarina Andrade, et al.
Published: (2025-04-01)

Varicella Zoster Virus Infection and Pregnancy: An Optimal Management Approach
by: Ana Ion, et al.
Published: (2025-02-01)

Varicella pneumonia in an immunocompetent adult patient: Case report and review of the literature
by: Carlos Felipe Arias-Osorio, et al.
Published: (2024-01-01)

Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China
by: Yang Zhang, et al.
Published: (2025-12-01)

Safety, long-term effectiveness, and immunogenicity of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy
by: Maša Bizjak, et al.
Published: (2025-08-01)

Real-world effectiveness of varicella vaccination in Guangzhou, China, 2017–2022: a matched case-control analysis
by: Junxi Li, et al.
Published: (2025-12-01)

Evaluating Rubella Immunity in Women of Reproductive Age in Mysuru: A Cross-Sectional Serosurvey
by: Beebi Ameena1*, et al.
Published: (2024-12-01)

Characterization of neutralizing versus binding antibody and T cell responses to varicella-zoster virus in the elderly
by: Suthee Mangmee, et al.
Published: (2025-04-01)

Cytokine levels are associated with the severity of varicella infections
by: Meijun Hao, et al.
Published: (2015-02-01)

Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand
by: Thanunrat Thongmee, et al.
Published: (2024-12-01)

Rational optimization of glycoprotein E (gE)-encoding mRNA for improved Varicella-zoster virus mRNA vaccine development
by: Lulu Huang, et al.
Published: (2024-12-01)

Motor Neuropathy in Varicella
by: J Gordon Millichap
Published: (1997-08-01)

Onychomadesis Induced by Varicella Infection – A Case Series
by: Sneha Manjunath, et al.
Published: (2025-06-01)

Investigation and analysis of influencing factors on the economic burden of varicella disease in Qingyang, China, 2024
by: Beiqin Liu, et al.
Published: (2025-12-01)